Pablo Labaig-Jimenez

Fulham Road
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

"SMAC"-down for the apoptosis-restoring drug, Xevinapant: What does its story reveal?

Targeting Regulatory T Cells for Cancer Immunotherapy: Promises and Pitfalls.

Targeting regulatory T cells for cancer immunotherapy: promises and pitfalls.

Showing 1-12 of 14

Last Updated: 09/26/2026